Skip to main content
MILESTONE SCIENTIFIC INC. logo

MILESTONE SCIENTIFIC INC. — Investor Relations & Filings

Ticker · MLSS ISIN · US59935P2092 US Manufacturing
Filings indexed 795 across all filing types
Latest filing 2003-10-08 Director's Dealing
Country US United States of America
Listing US MLSS

About MILESTONE SCIENTIFIC INC.

https://www.milestonescientific.com/

Milestone Scientific Inc. is a biomedical technology company that develops, patents, and commercializes computer-controlled injection and drug delivery systems. The company's core innovation is its proprietary DPS Dynamic Pressure Sensing Technology®, which provides real-time, objective pressure feedback at the needle tip during injections. This technology is the foundation for its key products. In the dental market, the STA Single Tooth Anesthesia® System is designed to deliver more precise and comfortable local anesthesia, reducing patient pain and fear, often without collateral numbness. For the medical market, the CompuFlo® Epidural Instrument helps clinicians accurately identify the epidural space, aiming to improve the safety, efficiency, and success rate of epidural procedures.

Recent filings

Filing Released Lang Actions
Director's Dealing 2003
Director's Dealing
2003-10-08 English
INITIAL FILING ON SCHEDULE 13G
Major Shareholding Notification
2003-10-08 English
FORM 4
Director's Dealing
2003-10-02 English
FORM 4
Director's Dealing
2003-10-02 English
POST-EFFECTIVE AMENDMENT TO FORM S-2
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus filed with the SEC, specifically a Post-Effective Amendment No.1 to Form S-2 Registration Statement under the Securities Act of 1933. It includes information about the offering of common stock by selling stockholders, use of proceeds, risk factors, and other details typical of a securities registration statement. The document is not an annual report, earnings release, or management discussion, but rather a capital raising and securities registration filing. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document length (15,000 characters) and detailed content confirm it is the filing itself, not just an announcement. Therefore, the correct classification is CAP with high confidence.
2003-09-16 English
QUARTERLY REPORT
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB' and is described as a 'QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2003.' It contains detailed unaudited condensed consolidated financial statements, including balance sheets, statements of operations, cash flows, notes to financial statements, and management's discussion and analysis. The document length is 15,000 characters, indicating it is a full report rather than a brief announcement. The presence of quarterly financial data and management discussion confirms this is an interim quarterly report. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2003-08-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.